Our Opinion

I-MAB is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

In the following press release company mentioned the usage of animals for drug testing.

“TJ202/MOR202 is a differentiated antibody originally developed by MorphoSys AG that has shown promise in preclinical animal studies and early human clinical trials.” Read the full article

Company Description

Company Website: http://www.i-mabbiopharma.com